JP Patent

JP4455321B2 — カルバメート置換ピラゾロピリジン類

Assigned to Bayer Pharma AG · Expires 2010-04-21 · 16y expired

What this patent protects

Patent listed against Adempas.

Drugs covered by this patent

Patent Metadata

Patent number
JP4455321B2
Jurisdiction
JP
Classification
—
Expires
2010-04-21
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharma AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.